VSIG1 Antibody [DyLight 550]
Novus Biologicals, part of Bio-Techne | Catalog # AF5324L
Conjugate
Catalog #
Key Product Details
Species Reactivity
Mouse, Rat
Applications
Western Blot
Label
DyLight 550 (Excitation = 562 nm, Emission = 576 nm)
Antibody Source
Polyclonal Goat IgG
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Product Specifications
Immunogen
Mouse myeloma cell line NS0-derived recombinant mouse VSIG1
Val23-Glu234
Accession # BAE35812
Val23-Glu234
Accession # BAE35812
Specificity
Detects mouse and rat VSIG1 in direct ELISAs and Western blots. In direct ELISAs, approximately 5% cross‑reactivity with recombinant human (rh) VSIG1 is observed and less than 1% cross‑reactivity with recombinant mouse (rm) VSIG2, rmVSIG3, rmVSIG4, and rhVSIG3 is observed.
Clonality
Polyclonal
Host
Goat
Isotype
IgG
Applications for VSIG1 Antibody [DyLight 550]
Application
Recommended Usage
Western Blot
Optimal dilutions of this antibody should be experimentally determined.
Application Notes
Optimal dilution of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Antigen Affinity-purified
Formulation
50mM Sodium Borate
Preservative
0.05% Sodium Azide
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C in the dark.
Background: VSIG1
Long Name
V-Set and Immunoglobulin Domain Containing 1
Alternate Names
GPA34
Gene Symbol
VSIG1
Additional VSIG1 Products
Product Documents for VSIG1 Antibody [DyLight 550]
Product Specific Notices for VSIG1 Antibody [DyLight 550]
DyLight (R) is a trademark of Thermo Fisher Scientific Inc. and its subsidiaries.
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...